[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2024; 8: (6) ; 10.12208/j.ijcr.20240227 .

Observation of clinical efficacy of Pulhanlin's decoction for removing lump in uterine fibroids by addition and reduction of syndrome differentiation
壶山林氏破瘕散加减辨证治疗子宫肌瘤的临床疗效观察

作者: 林润立 *

福州壶山医学研究所 福建福州

*通讯作者: 林润立,单位:福州壶山医学研究所 福建福州;

引用本文: 林润立 壶山林氏破瘕散加减辨证治疗子宫肌瘤的临床疗效观察[J]. 国际临床研究杂志, 2024; 8: (6) : 123-125.
Published: 2024/6/29 15:16:18

摘要

目的 子宫肌瘤属于女性生殖器良性肿瘤,是临床常见疾病,在所有妇科肿瘤中约占50%,该疾病具有发病慢、反复发作等显著特点,临床以药物和手术治疗为主,但手术治疗具有创伤性,术后并发症多,而西药治疗效果不尽人意。因此本文探析壶山林氏破瘕散加减辨证治疗子宫肌瘤的临床疗效观察。方法 此次研究选取2022年9月-2023年9月期间,壶山医学研究所以及壶山中医门诊部接诊收治的90例子宫肌瘤患者作为研究对象,对比不同治疗方案的两组患者临床治疗效果。结果 研究组治疗有效率为95.56%,复发率为13.33%,参照组依次为82.22%和37.78%,P<0.05,组间存在对比性,但在不良反应发生率方面没有明显差异(P>0.05)。结论 壶山林氏破瘕散加减辨证治疗子宫肌瘤是根据患者的症状辩证分型,不同的证型采取不同的治疗,进而可以从根本上将病灶祛除,达到标本兼治的效果,患者不良反应少,临床对症处理疗效显著,具有广泛临床推广价值。

关键词: 壶山林氏;破瘕散;子宫肌瘤;中医辨证;临床效果

Abstract

Objective Uterine fibroids, a benign tumor of female genitalia, are common clinical diseases, accounting for about 50% of all gynecological tumors. This disease has significant characteristics such as slow onset and repeated attacks. Clinical treatment is mainly drug and surgical treatment, but surgical treatment is traumatic and has many postoperative complications, and the therapeutic effect of western medicine is unsatisfactory. Therefore, this article analyzes the clinical curative effect observation of Pulhanlin's decoction of removing lump in the treatment of uterine fibroids by adding and reducing syndrome differentiation.
Methods In this study, 90 patients with uterine fibroids admitted and treated in Huashan Medical Research Institute and Huashan Traditional Chinese Medicine Outpatient Department from September 2022 to September 2023 were selected as the research objects, and the clinical treatment effect of the two groups of patients with different treatment schemes was compared.
Results The effective rate and recurrence rate in the study group were 95.56% and 13.33%, respectively, in the reference group were 82.22% and 37.78%, P < 0.05. There was a contrast between the groups, but no significant difference in the incidence of adverse reactions (P > 0.05).
Conclusion   The treatment of uterine fibroids with the addition and subtraction of Pulhanlin's tumor is based on the dialectical classification of patients' symptoms. Different types of symptoms can be treated differently, which can fundamentally remove the lesions and achieve the effect of treating both symptoms and root causes. The patients have less adverse reactions, and the clinical symptomatic treatment has significant curative effect, which has extensive clinical promotion value.

Key words: Huashan Lin; Rupture of mass; Uterine fibroids; TCM syndrome differentiation; Clinical effect

参考文献 References

[1] Giuliani E, As-Sanie S, Marsh E E. Epidemiology and management of uterine fibroids [J]. Inter J Gynecol Obstet, 2020, 149(2):3-9.

[2] 王远行,方慧彬,仝进毅.微创腹腔镜子宫肌瘤剔除术与传统开腹手术治疗子宫肌瘤的效果分析[J].中华肿瘤防治杂志,2020,000(001):2.

[3] 黄丽影,韩军香.桂枝茯苓汤联合针灸治疗气虚血瘀型子宫肌瘤患者的疗效及雌激素水平分析[J].疾病监测与控制,2022,16(5):387-389,393.

[4] 张娜,陈梅英,林紫瑜.消癥汤联合耳穴压豆防治子宫肌瘤剔除术后复发的疗效分析[J].中医临床研究,2022, 14(08): 105-107.

[5] JACOB M, RICHTER R, SEHOULI J, et al. Evaluation of biomarkers in myoma patients: a prospective study investigating the role of LDH, CA125, and IGF-1 after uterus-preserving surgical therapy [J]. Gynecol Obstet Invest, 2021,86(1-2):100-107.

[6] 黄静谊.优质护理在子宫肌瘤患者护理中的实施效果分析[J].中国医药指南,2022,20(22):37-40.

[7] 郭艳雪,陈洁,陈香,等.米非司酮不同剂量对子宫肌瘤患者瘤体大小及卵巢功能的影响[J].现代诊断与治疗,2021, 32(02):217-218.

[8] 何瑛 子宫腺肌瘤保守治疗的影响研究 . 家庭医药·就医选药, 2021 (1) :76-77.